Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q30394326)
Watch
English
Needle-free influenza vaccination.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
title
Needle-free influenza vaccination
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
author
Wouter L J Hinrichs
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
Henderik W Frijlink
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
Anke Huckriede
series ordinal
5
object named as
Anke Huckriede
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
author name string
Jean-Pierre Amorij
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
Jan C Wilschut
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
publication date
1 October 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
published in
Lancet Infectious Diseases
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
volume
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
issue
10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
page(s)
699-711
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
cites work
Needle-free vaccine delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization without needles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Needle-free vaccine delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccine delivery--current trends and future
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel approaches to vaccine delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antigen delivery systems
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal Influenza Vaccine in a Working Population
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of stable influenza vaccine powder formulations: challenges and possibilities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Innate signaling and regulation of Dendritic cell immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular and cellular signatures of human vaccine adjuvants.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Towards an understanding of the adjuvant action of aluminium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent advances in antigen processing and presentation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New insights into the early molecular events underlying B cell activation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal vaccines: the promise and the challenge
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nasal delivery systems and their effect on deposition and absorption
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enteric immunization of mice against influenza with recombinant vaccinia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trends in the technology-driven development of new inhalation devices
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvants: progress, regress and pandemic preparedness
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The virosome concept for influenza vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal immunization with influenza vaccine and a detoxified mutant of heat labile enterotoxin from Escherichia coli (LTK63)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in minipigs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunostimulating complexes (ISCOMs) for nasal vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Local immune responses following nasal delivery of an adjuvanted influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effective nasal influenza vaccine delivery using chitosan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chitosan as a novel nasal delivery system for vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sublingual vaccination with influenza virus protects mice against lethal viral infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcutaneous immunization with inactivated influenza virus induces protective immune responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal powder immunization of mice and monkeys with an influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New adjuvants: EU regulatory developments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Search for Herpesviruses in cerebrospinal fluid of facial palsy patients by PCR.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Animal models in influenza vaccine testing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Animal models for the preclinical evaluation of candidate influenza vaccines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
T cell responses are better correlates of vaccine protection in the elderly
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preservation of influenza virosome structure and function during freeze-drying and storage
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal, cold-adapted, live, attenuated influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Noninvasive delivery technologies: respiratory delivery of vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anthrax vaccine powder formulations for nasal mucosal delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Formulation of a dry powder influenza vaccine for nasal delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the clearance characteristics of bioadhesive systems in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo evaluation of nicotine lyophilised nasal insert in sheep
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drug delivery to the nasal cavity: in vitro and in vivo assessment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Devices for aerosol delivery to treat sinusitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel strategies of aerosolic pharmacotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal immunity and vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal immunity: implications for vaccine development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influenza Antibody in Human Respiratory Secretions after Subcutaneous or Respiratory Immunization with Inactivated Virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy of the A2/Aichi/68 strain in inhaled influenza immunisation against the A/England/42/72 variant.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A review of the development of Respimat Soft Mist Inhaler
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary vaccine delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety evaluation of pulmonary influenza vaccination in healthy and "asthmatic" mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Delivery of bioactive peptides and proteins across oral (buccal) mucosa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overview and research agenda arising from the 5th World Workshop on Oral Health and Disease in AIDS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of gamma delta T cells in mouse buccal epithelium following antigen priming
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
M cells at locations outside the gut.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human salivary immunoglobulin and antigen-specific antibody activity after tonsillectomy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Noninjection routes for immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sublingual immunization induces broad-based systemic and mucosal immune responses in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization against influenza in humans using an oral enteric-coated killed virus vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Time-controlled oral delivery systems for colon targeting
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Topical vaccination: the skin as a unique portal to adaptive immune responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum antibody responses after intradermal vaccination against influenza
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose sparing with intradermal injection of influenza vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunogenicity and safety of intradermal influenza vaccination in healthy older adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody responses after dose-sparing intradermal influenza vaccination.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of intradermal vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microneedles for transdermal drug delivery: a minireview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Needle-free liquid jet injections: mechanisms and applications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current status and future prospects of needle-free liquid jet injectors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A needle-free approach for topical immunization: antigen delivery via vesicular carrier system(s).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcutaneous immunization and immunostimulant strategies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal powder immunization against influenza
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transdermal influenza immunization with vaccine-coated microneedle arrays
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coating formulations for microneedles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dissolving microneedles for transdermal drug delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970157-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1473-3099(10)70157-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
PubMed publication ID
20883966
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20883966
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20883966%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
